Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Maria, Patelli Lima"'
Autor:
Mario Peribañez-Gonzalez, Hugo Cheinquer, Lino Rodrigues, Maria Patelli Lima, Mário Reis Álvares-da-Silva, José Madruga, Edison Roberto Parise, Mário Guimarães Pessoa, Juvencio Furtado, Marcia Villanova, Adalgisa Ferreira, Felipe Mazzoleni, Ecio Nascimento, Giovanni Faria Silva, Linda Fredrick, Preethi Krishnan, Margaret Burroughs, Tania Reuter
Publikováno v:
Annals of Hepatology, Vol 20, Iss , Pp 100257- (2021)
Introduction and objectives: Glecaprevir/pibrentasvir is a highly effective and well tolerated treatment for hepatitis C infection. Brazilian patients were not included in the original development studies for glecaprevir/pibrentasvir. This study aime
Externí odkaz:
https://doaj.org/article/75e03352e5c14ae3b8a648a24aab2538
Autor:
Jane, O'Halloran, Eyal, Kedar, Kevin J, Anstrom, Matthew W, McCarthy, Emily R, Ko, Patricia, Segura Nunez, Cynthia, Boucher, P Brian, Smith, Reynold A, Panettieri, Sabina, Mendivil Tuchia de Tai, Martin, Maillo, Akram, Khan, Alfredo J, Mena Lora, Matthias, Salathe, Gerardo, Capo, Daniel, Rodriguez Gonzalez, Thomas F, Patterson, Christopher, Palma, Horacio, Ariza, Maria, Patelli Lima, Anne M, Lachiewicz, John, Blamoun, Esteban, Nannini, Eduardo, Sprinz, Analia, Mykietiuk, Radica, Alicic, Adriana M, Rauseo, Cameron R, Wolfe, Britta, Wittig, Daniel K, Benjamin, Steven E, McNulty, Pearl, Zakroysky, Susan, Halabi, Sandra, Butler, Jane, Atkinson, Stacey J, Adam, Richard, Melsheimer, Soju, Chang, Lisa, LaVange, Michael, Proschan, Samuel A, Bozzette, William G, Powderly
Publikováno v:
medRxiv
BackgroundImmune dysregulation contributes to poorer outcomes in severe Covid-19. Immunomodulators targeting various pathways have improved outcomes. We investigated whether infliximab provides benefit over standard of care.MethodsWe conducted a mast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c636f160d614202fc158d1f4336836d
https://pubmed.ncbi.nlm.nih.gov/36172138
https://pubmed.ncbi.nlm.nih.gov/36172138